I was struck by Dr Cauchi’s concern that there was an implication that the petition was a reflection on his team, but I do not think that anybody, including the petitioner, wanted to it to be seen as that. However, there was a specific issue about whether a process available in other parts of Britain was not available in Scotland. There is still some question about that, because the petitioner suggests that if a particular hospital does not provide the service, patients could be referred elsewhere. That is clearly still an issue.
In terms of what more can be done, the petitioner has been effective in highlighting the area, which is not something that I knew anything about—why would I? That awareness raising has been important and it has required people involved in the system to focus on those concerns. There has been progress and I hope that there can be further progress.
My sense is that the committee feels that there is nothing more that we can do. We think that the petition has served the purpose that it sought to, which was to highlight gaps in provision. There is no doubt that the petitioner and has been very engaged, as has Dr Cauchi and his colleagues. The fact that we got evidence and two further submissions recognises that they take the issue seriously, and we find that exceptionally encouraging. I underline that neither we nor the petitioner, at any point, wanted to call into question the commitment of Dr Cauchi and his colleagues to the service of their patients.
I think that we should agree to close the petition under rule 15.7 of standing orders, recognising that significant work has been undertaken to explore the issue, which has concluded in a consensus statement that all patients with uveal melanoma should be offered six-monthly surveillance for liver metastases for the first 10 years after diagnosis, and that all new patients in Scotland are now offered prognostic biopsies. Are we agreed?
Members indicated agreement.